Earth Science Tech Inc. (OTC: ETST) is strategically positioning itself within the rapidly evolving telehealth industry, leveraging its proprietary technology and a vertically integrated business model to capture market share in sectors projected for substantial growth. The company, a holding firm actively managing operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and consumer markets, is focusing on two key areas: telehealth and peptide therapies.
The telehealth market is projected to reach $251.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.3% between 2025 and 2030, according to industry data (https://ibn.fm/EiRW6). Earth Science Tech has invested in subsidiaries such as DOConsultations LLC and Las Villas Health Care Inc. to tap into this demand. The company’s success is built on its proprietary tech and IT infrastructure, which provide a significant competitive edge in delivering telehealth services.
Additionally, ETST is capitalizing on the surging demand for peptide therapies, a market expected to hit $249 billion by 2033. Peptide therapies are gaining traction due to their clinical effectiveness in treating various conditions, and Earth Science Tech’s investments in this area align with the broader industry trend.
The company continues to push innovative tech development and expand vertical integration, aiming to create a seamless ecosystem that enhances patient care and operational efficiency. By acquiring and actively managing operating businesses, ETST is able to identify unique opportunities and steadily grow its market share.
For more information on Earth Science Tech, including the latest news and updates, visit the company’s newsroom at https://ibn.fm/ETST.
